|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Epilepsy, Post-Traumatic | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Brain Injuries | |||||
| Epilepsy | |||||
| 3 | More general conditions related to this trial | ||||
| Brain Diseases | |||||
| Central Nervous System Diseases | |||||
| Craniocerebral Trauma | |||||
| Disorders of Environmental Origin | |||||
| Nervous System Diseases | |||||
| Trauma, Nervous System | |||||
| Wounds and Injuries | |||||
| 4 | Interventions listed in this trial | ||||
| Levetiracetam | |||||
| Placebo | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Etiracetam | |||||
| 6 | More general drug interventions related to this trial | ||||
| Anticonvulsants | |||||
| Central Nervous System Agents | |||||
| Nootropic Agents | |||||
| Pharmacologic Actions | |||||
| Therapeutic Uses | |||||
| 7 | Sponsors listed in this trial | ||||
| Rennes University Hospital | |||||
| UCB | |||||